nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethobenzamide—Papaverine—PDE4B—hematologic cancer	0.0112	0.382	CrCbGaD
Trimethobenzamide—Verapamil—ABCC3—hematologic cancer	0.00544	0.186	CrCbGaD
Trimethobenzamide—Verapamil—SLC22A1—hematologic cancer	0.00378	0.129	CrCbGaD
Trimethobenzamide—Hypersensitivity—Methoxsalen—hematologic cancer	0.00317	0.00327	CcSEcCtD
Trimethobenzamide—Drowsiness—Mitoxantrone—hematologic cancer	0.00316	0.00326	CcSEcCtD
Trimethobenzamide—Blood disorder—Epirubicin—hematologic cancer	0.00315	0.00325	CcSEcCtD
Trimethobenzamide—Vision blurred—Lenalidomide—hematologic cancer	0.00314	0.00324	CcSEcCtD
Trimethobenzamide—Convulsion—Vinblastine—hematologic cancer	0.00312	0.00322	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Mercaptopurine—hematologic cancer	0.00308	0.00318	CcSEcCtD
Trimethobenzamide—Somnolence—Procarbazine—hematologic cancer	0.00308	0.00317	CcSEcCtD
Trimethobenzamide—Jaundice—Irinotecan—hematologic cancer	0.00308	0.00317	CcSEcCtD
Trimethobenzamide—Jaundice—Mitoxantrone—hematologic cancer	0.00308	0.00317	CcSEcCtD
Trimethobenzamide—Cramp muscle—Etoposide—hematologic cancer	0.00307	0.00316	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Daunorubicin—hematologic cancer	0.00304	0.00313	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Clofarabine—hematologic cancer	0.00304	0.00313	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Pentostatin—hematologic cancer	0.00303	0.00312	CcSEcCtD
Trimethobenzamide—Somnolence—Dasatinib—hematologic cancer	0.00302	0.00311	CcSEcCtD
Trimethobenzamide—Somnolence—Bexarotene—hematologic cancer	0.00302	0.00311	CcSEcCtD
Trimethobenzamide—Diarrhoea—Nelarabine—hematologic cancer	0.00302	0.00311	CcSEcCtD
Trimethobenzamide—Convulsion—Melphalan—hematologic cancer	0.00297	0.00306	CcSEcCtD
Trimethobenzamide—Muscle spasms—Bortezomib—hematologic cancer	0.00295	0.00304	CcSEcCtD
Trimethobenzamide—Hypotension—Nilotinib—hematologic cancer	0.00293	0.00302	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Idarubicin—hematologic cancer	0.00292	0.00301	CcSEcCtD
Trimethobenzamide—Blood disorder—Doxorubicin—hematologic cancer	0.00292	0.00301	CcSEcCtD
Trimethobenzamide—Hypotension—Imatinib—hematologic cancer	0.00292	0.003	CcSEcCtD
Trimethobenzamide—Dizziness—Nelarabine—hematologic cancer	0.00292	0.003	CcSEcCtD
Trimethobenzamide—Vision blurred—Bortezomib—hematologic cancer	0.00289	0.00298	CcSEcCtD
Trimethobenzamide—Hypotension—Cladribine—hematologic cancer	0.00287	0.00295	CcSEcCtD
Trimethobenzamide—Diarrhoea—Mercaptopurine—hematologic cancer	0.00286	0.00295	CcSEcCtD
Trimethobenzamide—Dizziness—Methoxsalen—hematologic cancer	0.00285	0.00294	CcSEcCtD
Trimethobenzamide—Convulsion—Hydroxyurea—hematologic cancer	0.00285	0.00293	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Teniposide—hematologic cancer	0.00284	0.00293	CcSEcCtD
Trimethobenzamide—Diarrhoea—Clofarabine—hematologic cancer	0.00282	0.00291	CcSEcCtD
Trimethobenzamide—Diarrhoea—Daunorubicin—hematologic cancer	0.00282	0.00291	CcSEcCtD
Trimethobenzamide—Diarrhoea—Pentostatin—hematologic cancer	0.00281	0.0029	CcSEcCtD
Trimethobenzamide—Diarrhoea—Anagrelide—hematologic cancer	0.00281	0.0029	CcSEcCtD
Trimethobenzamide—Somnolence—Imatinib—hematologic cancer	0.00277	0.00286	CcSEcCtD
Trimethobenzamide—Headache—Nelarabine—hematologic cancer	0.00276	0.00285	CcSEcCtD
Trimethobenzamide—Dizziness—Clofarabine—hematologic cancer	0.00273	0.00281	CcSEcCtD
Trimethobenzamide—Dizziness—Daunorubicin—hematologic cancer	0.00273	0.00281	CcSEcCtD
Trimethobenzamide—Somnolence—Cladribine—hematologic cancer	0.00273	0.00281	CcSEcCtD
Trimethobenzamide—Dizziness—Anagrelide—hematologic cancer	0.00272	0.0028	CcSEcCtD
Trimethobenzamide—Dizziness—Pentostatin—hematologic cancer	0.00272	0.0028	CcSEcCtD
Trimethobenzamide—Diarrhoea—Idarubicin—hematologic cancer	0.00271	0.00279	CcSEcCtD
Trimethobenzamide—Headache—Methoxsalen—hematologic cancer	0.0027	0.00278	CcSEcCtD
Trimethobenzamide—Vision blurred—Thiotepa—hematologic cancer	0.0027	0.00278	CcSEcCtD
Trimethobenzamide—Muscle spasms—Thalidomide—hematologic cancer	0.00266	0.00274	CcSEcCtD
Trimethobenzamide—Trimethoprim—ABCB1—hematologic cancer	0.00266	0.091	CrCbGaD
Trimethobenzamide—Convulsion—Bortezomib—hematologic cancer	0.00266	0.00274	CcSEcCtD
Trimethobenzamide—Verapamil—ABCG2—hematologic cancer	0.00264	0.0904	CrCbGaD
Trimethobenzamide—Diarrhoea—Teniposide—hematologic cancer	0.00264	0.00272	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Busulfan—hematologic cancer	0.00263	0.00271	CcSEcCtD
Trimethobenzamide—Hypotension—Melphalan—hematologic cancer	0.00261	0.00269	CcSEcCtD
Trimethobenzamide—Vision blurred—Thalidomide—hematologic cancer	0.00261	0.00269	CcSEcCtD
Trimethobenzamide—Headache—Daunorubicin—hematologic cancer	0.00259	0.00266	CcSEcCtD
Trimethobenzamide—Headache—Clofarabine—hematologic cancer	0.00259	0.00266	CcSEcCtD
Trimethobenzamide—Headache—Anagrelide—hematologic cancer	0.00257	0.00265	CcSEcCtD
Trimethobenzamide—Headache—Pentostatin—hematologic cancer	0.00257	0.00265	CcSEcCtD
Trimethobenzamide—Coma—Methotrexate—hematologic cancer	0.00257	0.00265	CcSEcCtD
Trimethobenzamide—Jaundice—Etoposide—hematologic cancer	0.00256	0.00264	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Procarbazine—hematologic cancer	0.00255	0.00263	CcSEcCtD
Trimethobenzamide—Hypotension—Lenalidomide—hematologic cancer	0.00254	0.00262	CcSEcCtD
Trimethobenzamide—Vision blurred—Carmustine—hematologic cancer	0.0025	0.00258	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Bexarotene—hematologic cancer	0.0025	0.00258	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Dasatinib—hematologic cancer	0.0025	0.00258	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Fludarabine—hematologic cancer	0.0025	0.00257	CcSEcCtD
Trimethobenzamide—Headache—Idarubicin—hematologic cancer	0.00248	0.00256	CcSEcCtD
Trimethobenzamide—Vision blurred—Alitretinoin—hematologic cancer	0.00248	0.00256	CcSEcCtD
Trimethobenzamide—Convulsion—Thiotepa—hematologic cancer	0.00248	0.00255	CcSEcCtD
Trimethobenzamide—Colchicine—ABCB1—hematologic cancer	0.00245	0.084	CrCbGaD
Trimethobenzamide—Vision blurred—Ifosfamide—hematologic cancer	0.00245	0.00253	CcSEcCtD
Trimethobenzamide—Diarrhoea—Busulfan—hematologic cancer	0.00244	0.00252	CcSEcCtD
Trimethobenzamide—Somnolence—Lenalidomide—hematologic cancer	0.00242	0.00249	CcSEcCtD
Trimethobenzamide—Headache—Teniposide—hematologic cancer	0.00242	0.00249	CcSEcCtD
Trimethobenzamide—Coma—Epirubicin—hematologic cancer	0.00241	0.00248	CcSEcCtD
Trimethobenzamide—Convulsion—Thalidomide—hematologic cancer	0.0024	0.00247	CcSEcCtD
Trimethobenzamide—Somnolence—Hydroxyurea—hematologic cancer	0.00238	0.00246	CcSEcCtD
Trimethobenzamide—Muscle spasms—Irinotecan—hematologic cancer	0.00237	0.00245	CcSEcCtD
Trimethobenzamide—Diarrhoea—Procarbazine—hematologic cancer	0.00237	0.00244	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Chlorambucil—hematologic cancer	0.00236	0.00244	CcSEcCtD
Trimethobenzamide—Dizziness—Busulfan—hematologic cancer	0.00236	0.00243	CcSEcCtD
Trimethobenzamide—Hypotension—Bortezomib—hematologic cancer	0.00234	0.00241	CcSEcCtD
Trimethobenzamide—Vision blurred—Mitoxantrone—hematologic cancer	0.00233	0.0024	CcSEcCtD
Trimethobenzamide—Diarrhoea—Dasatinib—hematologic cancer	0.00232	0.00239	CcSEcCtD
Trimethobenzamide—Diarrhoea—Bexarotene—hematologic cancer	0.00232	0.00239	CcSEcCtD
Trimethobenzamide—Hypotension—Bleomycin—hematologic cancer	0.00232	0.00239	CcSEcCtD
Trimethobenzamide—Diarrhoea—Fludarabine—hematologic cancer	0.00232	0.00239	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Nilotinib—hematologic cancer	0.00231	0.00238	CcSEcCtD
Trimethobenzamide—Convulsion—Carmustine—hematologic cancer	0.0023	0.00237	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Imatinib—hematologic cancer	0.0023	0.00237	CcSEcCtD
Trimethobenzamide—Dizziness—Procarbazine—hematologic cancer	0.00229	0.00236	CcSEcCtD
Trimethobenzamide—Hypotension—Vinorelbine—hematologic cancer	0.00228	0.00235	CcSEcCtD
Trimethobenzamide—Convulsion—Alitretinoin—hematologic cancer	0.00228	0.00235	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Cladribine—hematologic cancer	0.00226	0.00233	CcSEcCtD
Trimethobenzamide—Convulsion—Ifosfamide—hematologic cancer	0.00225	0.00232	CcSEcCtD
Trimethobenzamide—Dizziness—Bexarotene—hematologic cancer	0.00225	0.00231	CcSEcCtD
Trimethobenzamide—Dizziness—Dasatinib—hematologic cancer	0.00225	0.00231	CcSEcCtD
Trimethobenzamide—Headache—Busulfan—hematologic cancer	0.00224	0.00231	CcSEcCtD
Trimethobenzamide—Coma—Doxorubicin—hematologic cancer	0.00223	0.00229	CcSEcCtD
Trimethobenzamide—Convulsion—Vincristine—hematologic cancer	0.0022	0.00226	CcSEcCtD
Trimethobenzamide—Diarrhoea—Chlorambucil—hematologic cancer	0.0022	0.00226	CcSEcCtD
Trimethobenzamide—Headache—Procarbazine—hematologic cancer	0.00217	0.00224	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Vinblastine—hematologic cancer	0.00217	0.00223	CcSEcCtD
Trimethobenzamide—Muscle spasms—Cisplatin—hematologic cancer	0.00216	0.00222	CcSEcCtD
Trimethobenzamide—Diarrhoea—Nilotinib—hematologic cancer	0.00215	0.00221	CcSEcCtD
Trimethobenzamide—Convulsion—Mitoxantrone—hematologic cancer	0.00214	0.0022	CcSEcCtD
Trimethobenzamide—Diarrhoea—Imatinib—hematologic cancer	0.00214	0.0022	CcSEcCtD
Trimethobenzamide—Headache—Bexarotene—hematologic cancer	0.00213	0.00219	CcSEcCtD
Trimethobenzamide—Headache—Dasatinib—hematologic cancer	0.00213	0.00219	CcSEcCtD
Trimethobenzamide—Headache—Fludarabine—hematologic cancer	0.00212	0.00219	CcSEcCtD
Trimethobenzamide—Vision blurred—Cisplatin—hematologic cancer	0.00211	0.00218	CcSEcCtD
Trimethobenzamide—Hypotension—Thalidomide—hematologic cancer	0.00211	0.00217	CcSEcCtD
Trimethobenzamide—Diarrhoea—Cladribine—hematologic cancer	0.0021	0.00216	CcSEcCtD
Trimethobenzamide—Dizziness—Nilotinib—hematologic cancer	0.00208	0.00214	CcSEcCtD
Trimethobenzamide—Somnolence—Thiotepa—hematologic cancer	0.00208	0.00214	CcSEcCtD
Trimethobenzamide—Dizziness—Imatinib—hematologic cancer	0.00206	0.00213	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Melphalan—hematologic cancer	0.00206	0.00212	CcSEcCtD
Trimethobenzamide—Dizziness—Cladribine—hematologic cancer	0.00203	0.00209	CcSEcCtD
Trimethobenzamide—Hypotension—Carmustine—hematologic cancer	0.00203	0.00209	CcSEcCtD
Trimethobenzamide—Diarrhoea—Vinblastine—hematologic cancer	0.00201	0.00207	CcSEcCtD
Trimethobenzamide—Hypotension—Alitretinoin—hematologic cancer	0.00201	0.00207	CcSEcCtD
Trimethobenzamide—Somnolence—Thalidomide—hematologic cancer	0.00201	0.00207	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Lenalidomide—hematologic cancer	0.002	0.00206	CcSEcCtD
Trimethobenzamide—Hypotension—Ifosfamide—hematologic cancer	0.00198	0.00204	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00198	0.00204	CcSEcCtD
Trimethobenzamide—Muscle spasms—Etoposide—hematologic cancer	0.00198	0.00203	CcSEcCtD
Trimethobenzamide—Headache—Nilotinib—hematologic cancer	0.00197	0.00203	CcSEcCtD
Trimethobenzamide—Headache—Imatinib—hematologic cancer	0.00196	0.00201	CcSEcCtD
Trimethobenzamide—Dizziness—Vinblastine—hematologic cancer	0.00195	0.002	CcSEcCtD
Trimethobenzamide—Convulsion—Cisplatin—hematologic cancer	0.00194	0.002	CcSEcCtD
Trimethobenzamide—Hypotension—Vincristine—hematologic cancer	0.00193	0.00199	CcSEcCtD
Trimethobenzamide—Somnolence—Carmustine—hematologic cancer	0.00193	0.00199	CcSEcCtD
Trimethobenzamide—Headache—Cladribine—hematologic cancer	0.00192	0.00198	CcSEcCtD
Trimethobenzamide—Diarrhoea—Melphalan—hematologic cancer	0.00191	0.00197	CcSEcCtD
Trimethobenzamide—Vision blurred—Prednisolone—hematologic cancer	0.00191	0.00197	CcSEcCtD
Trimethobenzamide—Somnolence—Alitretinoin—hematologic cancer	0.00191	0.00197	CcSEcCtD
Trimethobenzamide—Somnolence—Ifosfamide—hematologic cancer	0.00189	0.00194	CcSEcCtD
Trimethobenzamide—Hypotension—Mitoxantrone—hematologic cancer	0.00188	0.00194	CcSEcCtD
Trimethobenzamide—Hypotension—Irinotecan—hematologic cancer	0.00188	0.00194	CcSEcCtD
Trimethobenzamide—Diarrhoea—Lenalidomide—hematologic cancer	0.00186	0.00192	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Bortezomib—hematologic cancer	0.00184	0.0019	CcSEcCtD
Trimethobenzamide—Headache—Vinblastine—hematologic cancer	0.00184	0.0019	CcSEcCtD
Trimethobenzamide—Diarrhoea—Hydroxyurea—hematologic cancer	0.00184	0.00189	CcSEcCtD
Trimethobenzamide—Hypotension—Gemcitabine—hematologic cancer	0.00183	0.00189	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Bleomycin—hematologic cancer	0.00183	0.00189	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Vinorelbine—hematologic cancer	0.0018	0.00186	CcSEcCtD
Trimethobenzamide—Dizziness—Lenalidomide—hematologic cancer	0.0018	0.00185	CcSEcCtD
Trimethobenzamide—Somnolence—Irinotecan—hematologic cancer	0.00179	0.00185	CcSEcCtD
Trimethobenzamide—Somnolence—Mitoxantrone—hematologic cancer	0.00179	0.00185	CcSEcCtD
Trimethobenzamide—Convulsion—Etoposide—hematologic cancer	0.00178	0.00183	CcSEcCtD
Trimethobenzamide—Dizziness—Hydroxyurea—hematologic cancer	0.00177	0.00183	CcSEcCtD
Trimethobenzamide—Convulsion—Prednisolone—hematologic cancer	0.00176	0.00181	CcSEcCtD
Trimethobenzamide—Somnolence—Gemcitabine—hematologic cancer	0.00175	0.0018	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Thiotepa—hematologic cancer	0.00172	0.00177	CcSEcCtD
Trimethobenzamide—Diarrhoea—Bortezomib—hematologic cancer	0.00171	0.00176	CcSEcCtD
Trimethobenzamide—Hypotension—Cisplatin—hematologic cancer	0.00171	0.00176	CcSEcCtD
Trimethobenzamide—Headache—Lenalidomide—hematologic cancer	0.0017	0.00176	CcSEcCtD
Trimethobenzamide—Headache—Hydroxyurea—hematologic cancer	0.00168	0.00173	CcSEcCtD
Trimethobenzamide—Diarrhoea—Vinorelbine—hematologic cancer	0.00167	0.00172	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Thalidomide—hematologic cancer	0.00166	0.00171	CcSEcCtD
Trimethobenzamide—Dizziness—Bortezomib—hematologic cancer	0.00166	0.00171	CcSEcCtD
Trimethobenzamide—Dizziness—Vinorelbine—hematologic cancer	0.00162	0.00167	CcSEcCtD
Trimethobenzamide—Convulsion—Triamcinolone—hematologic cancer	0.00161	0.00166	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Carmustine—hematologic cancer	0.0016	0.00165	CcSEcCtD
Trimethobenzamide—Diarrhoea—Thiotepa—hematologic cancer	0.0016	0.00165	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Alitretinoin—hematologic cancer	0.00158	0.00163	CcSEcCtD
Trimethobenzamide—Drowsiness—Methotrexate—hematologic cancer	0.00157	0.00162	CcSEcCtD
Trimethobenzamide—Headache—Bortezomib—hematologic cancer	0.00157	0.00162	CcSEcCtD
Trimethobenzamide—Hypotension—Etoposide—hematologic cancer	0.00157	0.00161	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Ifosfamide—hematologic cancer	0.00156	0.00161	CcSEcCtD
Trimethobenzamide—Diarrhoea—Thalidomide—hematologic cancer	0.00154	0.00159	CcSEcCtD
Trimethobenzamide—Dizziness—Thiotepa—hematologic cancer	0.00154	0.00159	CcSEcCtD
Trimethobenzamide—Headache—Vinorelbine—hematologic cancer	0.00153	0.00158	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Vincristine—hematologic cancer	0.00153	0.00157	CcSEcCtD
Trimethobenzamide—Dizziness—Thalidomide—hematologic cancer	0.00149	0.00154	CcSEcCtD
Trimethobenzamide—Somnolence—Etoposide—hematologic cancer	0.00149	0.00154	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Irinotecan—hematologic cancer	0.00149	0.00153	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00149	0.00153	CcSEcCtD
Trimethobenzamide—Diarrhoea—Carmustine—hematologic cancer	0.00148	0.00153	CcSEcCtD
Trimethobenzamide—Drowsiness—Epirubicin—hematologic cancer	0.00147	0.00152	CcSEcCtD
Trimethobenzamide—Diarrhoea—Alitretinoin—hematologic cancer	0.00147	0.00151	CcSEcCtD
Trimethobenzamide—Convulsion—Betamethasone—hematologic cancer	0.00147	0.00151	CcSEcCtD
Trimethobenzamide—Convulsion—Dexamethasone—hematologic cancer	0.00147	0.00151	CcSEcCtD
Trimethobenzamide—Headache—Thiotepa—hematologic cancer	0.00146	0.00151	CcSEcCtD
Trimethobenzamide—Diarrhoea—Ifosfamide—hematologic cancer	0.00145	0.0015	CcSEcCtD
Trimethobenzamide—Jaundice—Epirubicin—hematologic cancer	0.00144	0.00148	CcSEcCtD
Trimethobenzamide—Dizziness—Carmustine—hematologic cancer	0.00143	0.00148	CcSEcCtD
Trimethobenzamide—Dizziness—Alitretinoin—hematologic cancer	0.00142	0.00146	CcSEcCtD
Trimethobenzamide—Diarrhoea—Vincristine—hematologic cancer	0.00142	0.00146	CcSEcCtD
Trimethobenzamide—Headache—Thalidomide—hematologic cancer	0.00141	0.00146	CcSEcCtD
Trimethobenzamide—Dizziness—Ifosfamide—hematologic cancer	0.0014	0.00145	CcSEcCtD
Trimethobenzamide—Vision blurred—Prednisone—hematologic cancer	0.00139	0.00143	CcSEcCtD
Trimethobenzamide—Diarrhoea—Irinotecan—hematologic cancer	0.00138	0.00142	CcSEcCtD
Trimethobenzamide—Diarrhoea—Mitoxantrone—hematologic cancer	0.00138	0.00142	CcSEcCtD
Trimethobenzamide—Dizziness—Vincristine—hematologic cancer	0.00137	0.00141	CcSEcCtD
Trimethobenzamide—Drowsiness—Doxorubicin—hematologic cancer	0.00136	0.0014	CcSEcCtD
Trimethobenzamide—Headache—Carmustine—hematologic cancer	0.00136	0.0014	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Cisplatin—hematologic cancer	0.00135	0.00139	CcSEcCtD
Trimethobenzamide—Headache—Alitretinoin—hematologic cancer	0.00135	0.00139	CcSEcCtD
Trimethobenzamide—Diarrhoea—Gemcitabine—hematologic cancer	0.00134	0.00138	CcSEcCtD
Trimethobenzamide—Dizziness—Irinotecan—hematologic cancer	0.00133	0.00137	CcSEcCtD
Trimethobenzamide—Jaundice—Doxorubicin—hematologic cancer	0.00133	0.00137	CcSEcCtD
Trimethobenzamide—Headache—Vincristine—hematologic cancer	0.0013	0.00134	CcSEcCtD
Trimethobenzamide—Hypotension—Dexamethasone—hematologic cancer	0.00129	0.00133	CcSEcCtD
Trimethobenzamide—Hypotension—Betamethasone—hematologic cancer	0.00129	0.00133	CcSEcCtD
Trimethobenzamide—Convulsion—Prednisone—hematologic cancer	0.00128	0.00131	CcSEcCtD
Trimethobenzamide—Headache—Irinotecan—hematologic cancer	0.00126	0.0013	CcSEcCtD
Trimethobenzamide—Headache—Mitoxantrone—hematologic cancer	0.00126	0.0013	CcSEcCtD
Trimethobenzamide—Diarrhoea—Cisplatin—hematologic cancer	0.00125	0.00129	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Etoposide—hematologic cancer	0.00124	0.00127	CcSEcCtD
Trimethobenzamide—Headache—Gemcitabine—hematologic cancer	0.00123	0.00127	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Prednisolone—hematologic cancer	0.00122	0.00126	CcSEcCtD
Trimethobenzamide—Vision blurred—Methotrexate—hematologic cancer	0.00116	0.00119	CcSEcCtD
Trimethobenzamide—Diarrhoea—Etoposide—hematologic cancer	0.00115	0.00118	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Triamcinolone—hematologic cancer	0.00112	0.00115	CcSEcCtD
Trimethobenzamide—Dizziness—Etoposide—hematologic cancer	0.00111	0.00114	CcSEcCtD
Trimethobenzamide—Muscle spasms—Epirubicin—hematologic cancer	0.00111	0.00114	CcSEcCtD
Trimethobenzamide—Verapamil—ABCB1—hematologic cancer	0.0011	0.0376	CrCbGaD
Trimethobenzamide—Dizziness—Prednisolone—hematologic cancer	0.00109	0.00113	CcSEcCtD
Trimethobenzamide—Vision blurred—Epirubicin—hematologic cancer	0.00109	0.00112	CcSEcCtD
Trimethobenzamide—Convulsion—Methotrexate—hematologic cancer	0.00107	0.0011	CcSEcCtD
Trimethobenzamide—Headache—Etoposide—hematologic cancer	0.00105	0.00108	CcSEcCtD
Trimethobenzamide—Headache—Prednisolone—hematologic cancer	0.00104	0.00107	CcSEcCtD
Trimethobenzamide—Muscle spasms—Doxorubicin—hematologic cancer	0.00102	0.00106	CcSEcCtD
Trimethobenzamide—Dizziness—Triamcinolone—hematologic cancer	0.00101	0.00104	CcSEcCtD
Trimethobenzamide—Vision blurred—Doxorubicin—hematologic cancer	0.001	0.00103	CcSEcCtD
Trimethobenzamide—Convulsion—Epirubicin—hematologic cancer	0.000998	0.00103	CcSEcCtD
Trimethobenzamide—Headache—Triamcinolone—hematologic cancer	0.000953	0.000981	CcSEcCtD
Trimethobenzamide—Diarrhoea—Dexamethasone—hematologic cancer	0.000944	0.000973	CcSEcCtD
Trimethobenzamide—Diarrhoea—Betamethasone—hematologic cancer	0.000944	0.000973	CcSEcCtD
Trimethobenzamide—Hypotension—Methotrexate—hematologic cancer	0.000939	0.000967	CcSEcCtD
Trimethobenzamide—Convulsion—Doxorubicin—hematologic cancer	0.000923	0.000951	CcSEcCtD
Trimethobenzamide—Dizziness—Dexamethasone—hematologic cancer	0.000913	0.00094	CcSEcCtD
Trimethobenzamide—Dizziness—Betamethasone—hematologic cancer	0.000913	0.00094	CcSEcCtD
Trimethobenzamide—Somnolence—Methotrexate—hematologic cancer	0.000893	0.00092	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Prednisone—hematologic cancer	0.000885	0.000912	CcSEcCtD
Trimethobenzamide—Hypotension—Epirubicin—hematologic cancer	0.000878	0.000905	CcSEcCtD
Trimethobenzamide—Headache—Dexamethasone—hematologic cancer	0.000865	0.000891	CcSEcCtD
Trimethobenzamide—Headache—Betamethasone—hematologic cancer	0.000865	0.000891	CcSEcCtD
Trimethobenzamide—Somnolence—Epirubicin—hematologic cancer	0.000836	0.000861	CcSEcCtD
Trimethobenzamide—Diarrhoea—Prednisone—hematologic cancer	0.000822	0.000847	CcSEcCtD
Trimethobenzamide—Hypotension—Doxorubicin—hematologic cancer	0.000813	0.000837	CcSEcCtD
Trimethobenzamide—Dizziness—Prednisone—hematologic cancer	0.000795	0.000819	CcSEcCtD
Trimethobenzamide—Somnolence—Doxorubicin—hematologic cancer	0.000773	0.000796	CcSEcCtD
Trimethobenzamide—Headache—Prednisone—hematologic cancer	0.000753	0.000776	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Methotrexate—hematologic cancer	0.00074	0.000762	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Epirubicin—hematologic cancer	0.000693	0.000713	CcSEcCtD
Trimethobenzamide—Diarrhoea—Methotrexate—hematologic cancer	0.000687	0.000708	CcSEcCtD
Trimethobenzamide—Dizziness—Methotrexate—hematologic cancer	0.000664	0.000684	CcSEcCtD
Trimethobenzamide—Diarrhoea—Epirubicin—hematologic cancer	0.000643	0.000662	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Doxorubicin—hematologic cancer	0.000641	0.00066	CcSEcCtD
Trimethobenzamide—Headache—Methotrexate—hematologic cancer	0.000629	0.000648	CcSEcCtD
Trimethobenzamide—Dizziness—Epirubicin—hematologic cancer	0.000622	0.00064	CcSEcCtD
Trimethobenzamide—Diarrhoea—Doxorubicin—hematologic cancer	0.000595	0.000613	CcSEcCtD
Trimethobenzamide—Headache—Epirubicin—hematologic cancer	0.000589	0.000607	CcSEcCtD
Trimethobenzamide—Dizziness—Doxorubicin—hematologic cancer	0.000575	0.000592	CcSEcCtD
Trimethobenzamide—Headache—Doxorubicin—hematologic cancer	0.000545	0.000561	CcSEcCtD
